Weekly Insulin Awiqli Launches as Alternative to Daily Shots

Awiqli, a once-weekly insulin for Type 2 diabetes, has launched following FDA approval. It offers a significant convenience improvement for the 8 million Americans on insulin. Cost and insurance coverage details are still emerging.